Gábor Székely

Magnus Holdings Co., Ltd. is engaged in providing investment services. It is also involved in the activities of management consultancy. The company was founded on December 24, 2015 and is headquartered in Seoul, South Korea.

Gelmetix Ltd. offers a non-surgical procedure for the treatment of chronic lower back pain caused by degenerative disc disease. The firm develops a hydrogel to relieve back pain by enabling cells in the spinal disc to get back to normal functioning, which can be injected into the disc by a healthcare professional and replaces the need for invasive back surgery. The company was founded by Tony Freemont and Brian Saunders in 2012 and is headquartered in Cheshire, the United Kingdom.

Avelo AG is a Swiss company that aims to save lives by providing fast and actionable infectious disease diagnosis closer to the patient. Avelo is based in Schlieren, CH. The company's solution is a breath collection device that works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia. The company was founded in 2020 by Melanie Aregger and Tobias Broger, with Melanie Aregger serving as the CEO since 2020.

TITAL GmbH engages in the manufacture and distribution of aluminum and titanium alloy investment castings for the aerospace, defense, electronics, optical, medical technology, motorsport, as well as mechanical and civil engineering industry. The company was founded in 1974 and is headquartered in Bestwig, Germany.

DREHTAINER GmbH engages in the development and manufacture of special containers and vehicles in the fields of defense and nuclear technology, and provides solutions for industrial applications. Its products include expandable container, protected casualty transport, multi-purpose container, road blocker, protected driver's cab, container testbed, firing tunnel, container revolving frame, expandable container, lifting gear, laboratory container, handling equipment, shielding container, and medical container. The company was founded in 1974 and is headquartered in Valluhn, Germany.

Armira Partners GmbH & Co. KG (Armira) is an independent private equity firm founded in 2008. The firm is headquartered in Munich, Germany.

Eppendorf SE develops, manufactures, and distributes instruments and equipment for use in life-science research laboratories. The firm specializes in the areas of liquid, cell, and sample handling. Its products include pipettes, dispensers, centrifuges, bioreactor systems, cell culture and imaging consumables, centrifugation instruments, freezers, shakers, temperature control and mixing devices, as well as laboratory consumables. The company was founded by Heinrich Netheler and Hans Hinz in 1945 and is headquartered in Hamburg, Germany.

Attolight AG manufactures edge cathodoluminescence instruments to measure carrier dynamics in nanostructures. It also distributes electron microscopes. The company was founded by Samuel Sonderegger and Jean Berney in 2008 and is headquartered in Ecublens, Switzerland.

StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland.

V-ZUG Infra AG is a private company based in Berneck, Switzerland. and has subsidiaries in Germany.

Part of PUMA SE, Cosa Liebermann KK is a Japanese company that markets and distributes sporting goods and shoes manufactured by Puma. The company is based in Tokyo, Japan. Cosa Liebermann KK was acquired by PUMA SE on March 29, 2003 for $46.61 million.

Speratum Biopharma, Inc. is a pre-clinical stage biotechnology company based in Dover, DE. Speratum is focused on the research and development of targeted molecular therapeutics for the treatment of cancer. The company's primary focus is developing a multi-component therapeutic against multiple cancer types that includes a proprietary RNA interference (RNAi)-inducing mimic of mir-198, a naturally occurring microRNA involved in the pathogenesis of several solid cancers, combined with a novel biocompatible material suitable for systemic and targeted delivery of nucleic acids. Speratum's platforms for drug delivery and oligonucleotide administration have broad application potential, and have been out-licensed for multiple therapeutic and research modalities. The company was founded by Christian Marín-Müller, who has been the CEO since incorporation.